Related Experiment Video
Updated: Mar 10, 2026

Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Impact of pharmacy-based interventions on vaccination coverage among vulnerable and underserved populations: a
Borlini Stefania1, Pennisi Flavia2, Pinto Antonio1
1Faculty of Medicine, University Vita-Salute San Raffaele, via Olgettina, 58, 20132 Milan, Italy.
Background:
Vaccination coverage remains suboptimal among vulnerable and underserved adult populations. We investigated the effectiveness of pharmacy-based interventions in improving vaccine uptake in high-risk groups and the most effective strategies.
Methods:
A systematic search (PubMed/MEDLINE, Embase, Scopus; 26 July 2025) identified experimental and observational studies evaluating pharmacy-led vaccination interventions targeting adults ≥65 years or individuals aged 18-64 years with chronic conditions or limited healthcare access. The primary outcome was vaccination coverage. Odds ratios (ORs) were pooled using fixed- and random-effects models. Sensitivity analyses were conducted by intervention type and setting. Risk of bias was assessed using ROBINS-I, RoB 2, and NOS tools.
Results:
A total of 35 studies were included, encompassing over 1.3 million participants. In pre-post comparisons, pharmacy-based interventions nearly doubled vaccination uptake (random-effects OR = 1.88; 95% CI: 1.68-2.12). In case-control analyses, individuals exposed to pharmacist interventions were almost five times more likely to be vaccinated (random-effects OR = 4.87; 95% CI: 2.23-10.64). Multicomponent strategies and direct vaccine administration by pharmacists produced the most consistent improvements.
Conclusions:
Pharmacist-led vaccination interventions significantly increase vaccine uptake among vulnerable adults. The most effective approaches involved pharmacists included eligibility assessment, counselling, administration, and documentation, integrated within routine care workflows.
Related Concept Videos
Pharmaceutical Poisoning: Potential Scenarios
Analysis of Population Pharmacokinetic Data
Biopharmaceutics and Pharmacokinetics: Overview
Introduction To Health Care Delivery System
The Institute of Medicine (IOM) advocates for a patient-centered, effective, safe, timely, equitable, and effective healthcare system. The National Priorities...
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...

